Navigation Links
The Leukemia & Lymphoma Society and The University of Kansas Cancer Center Announce Innovative Partnership to Accelerate Drug Development
Date:1/7/2009

critically needed skills to the LLS research pipeline and expedites the advancement of new drugs to treat blood cancer patients," said Louis DeGennaro, Ph.D., LLS's chief scientific officer.

Through the partnership, LLS will initially provide up to $1.5 million to the university's Office of Therapeutics, Discovery and Development for the funded projects.

"The Leukemia & Lymphoma Society is a world-renowned cancer organization, and we are honored to be affiliated with such a prestigious and groundbreaking program," said Roy Jensen, M.D., director, The University of Kansas Cancer Center. "This partnership is a tremendous opportunity for us to make a significant impact on blood cancers, by leveraging the extraordinary capabilities we have in drug discovery, delivery and development. It will also assist us in our quest to achieve National Cancer Institute designation."

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society(R), headquartered in White Plains, NY, with 68 chapters in the United States and Canada, is the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. LLS's mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, LLS has invested more than $600 million in research specifically targeting leukemia, lymphoma and myeloma. Last year alone, LLS made 6.3 million contacts with patients, caregivers and healthcare professionals.

For more information about blood cancer, visit www.LLS.org or call LLS's Information Resource Center (IRC), a call center staffed by master's level social workers, nurses and health educators who provide information, support and resources to patients and their families and careg
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Grape Seed Extract Kills Leukemia Cells in Lab
2. Stem cells and leukemia battle for marrow microenvironment
3. Biopure Submits IND Application for Proposed Clinical Trial in Patients with Acute Myeloid Leukemia
4. Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting
5. Dismissed leukemia drug helps cll patients, studies show
6. Novel treatments show improvements in survival and response rates for leukemia and lymphoma
7. Novel Treatments Demonstrate Improvements in Overall Survival and Response Rates in Difficult-To-Treat Forms of Leukemia and Lymphoma
8. 50 years of hairy-cell leukemia research to be observed
9. Higher Chemo Drug Dose Prolongs Lives of Leukemia Patients
10. Adult survivors of childhood leukemia have lower bone mineral density, study finds
11. UCSD researchers identify potential new drug target for chronic leukemia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ment prolongs life remains unclear, researchers sa... -- New research suggests that enzyme replacement ...f people with Fabry disease, a rare illness that a...gressive disease, linked to the lack of an enzyme ..., can be fatal because it boosts the risk for a st...
(Date:12/2/2009)...SADENA, Calif., Dec. 2 ...received the Gold Seal of Approval from the Joint ...oke center. This means Huntington will join the n...ghout Los Angeles County. ,, "This is a signi...ant, a wonderful benefit for Pasadena and its surr...
(Date:12/2/2009)...N FRANCISCO, Dec. 2 In ...s are born contaminated with a plastics chemical l... must act immediately to protect infants and mothe...ls to ban bisphenol A, or BPA, in food and beverag...of California and Rep. Edward Markey of Massachuse...
(Date:12/2/2009)... , New Directors Represent Diverse Heal...RNewswire-USNewswire/ -- The membership of the Nat... to its Board of Directors and reappointed four cu...nt a wide range of healthcare stakeholders, includ..., and public and community healthcare. ,, The ...
(Date:12/2/2009)... ,, NEW YORK, Dec. 2 Care...ive care coordination, Advanced Illness Coordinat...izations in the last years of life as well as impr...ly caregivers without increasing mortality. These ...d in American Journal of Managed Care (November ...
Breaking Medicine News(10 mins):Health News:Huntington Hospital Earns Designation as Primary Stroke Center 2Health News:Pre-Polluted Babies: Congress Must Act to Protect Infants, Moms from Toxic Plastics Chemical BPA 2Health News:National Quality Forum Members Elect Nine Directors to Board 2Health News:National Quality Forum Members Elect Nine Directors to Board 3Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 2Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 3Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 4
...India's government said Friday it will soon introd...ckets but confessed it was having trouble overcomi...er, the new measures will allow tobacco manufactur... and crossbones symbol. "Some kind of warn...
...The Russian government will allocate one billion r...IV, Russia's chief doctor has said. "The ... billion rubles to boost current research for a HI...luding the Vector State Research Center of Virolog...
...A spurious medicine manufacturing unit was busted ... over Rs.20 million were seized, police said Satur... by Sankarlal Agarwal at Kantabanji town, over 400...hat he supplied the fake medicines to the neighbou...
...Overseas doctors, especially Indians, Jordanians a...June 29 and 30 failed bomb attacks in London and G...Lancet, there is a danger of such incidents being ...a report in the BBC, a major investigation has bee...
...Minimally invasive techniques for total knee repla...dic surgeon Dr. Raymond Eric Randle from the John ...id at Bangalore Friday. He was talking to...Surgeon, Wockhardt Hospitals. The demonstr...
...Oscar-winning actress Hilary Swank will soon be se...aims at supporting women who have lost their hair ...tene Beautiful Lengths drive encourages people to ...campaign from 2008, will donate her own hair too. ...
Other Medicine News:Health News:Indian, Iraqi Medics may Face Terror Stigma Overseas 2Health News:Hip and Knee Replacements Becoming More Patient-friendly 2Health News:Hip and Knee Replacements Becoming More Patient-friendly 3
(Date:12/2/2009)...PRNewswire/ -- TeamHealth Teleradiology ( www.thte...est provider of hospital-based clinical outsourcin...e teleradiology services for two groups in South C...th UpState Carolina Radiology located in Spartanbu...rovide services for the following four hospitals: ...
(Date:12/2/2009)... Dec. 2 Interleukin Gene...cal Center announced findings from a study perform...netics of osteoarthritis have been published this ...f Rheumatic Diseases and is available at http://a... Results from the study highlight importance of i...
(Date:12/2/2009)...ecember 2 DermaGen AB - part of th...ling company "Pergamum" -,today announced that Der...nical Phase I/IIa study. DermaGen AB is developing... atopic dermatitis. Atopic dermatitis is a chronic...skin,s weakened barrier,function make patients sus...
Breaking Medicine Technology:TeamHealth Teleradiology Announces New Contracts in South Carolina and Illinois 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 3Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 4Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 2Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 3Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 4Veteran Rehab Specialist Rafael Ibarra Joins Alliance Seating 26 Mobility in Georgia 54804 1Veteran Rehab Specialist Rafael Ibarra Joins Alliance Seating 26 Mobility in Georgia 54804 2Detroit Clinic Owner and Patient Recruiter Plead Guilty in 2415 Million Fraud Scheme 54802 1Detroit Clinic Owner and Patient Recruiter Plead Guilty in 2415 Million Fraud Scheme 54802 2Detroit Clinic Owner and Patient Recruiter Plead Guilty in 2415 Million Fraud Scheme 54802 3Detroit Clinic Owner and Patient Recruiter Plead Guilty in 2415 Million Fraud Scheme 54802 4WXYZ TV Channel 7 is On Your Side with Healthy Living for Kids 3B Free Immunizations for Children on Sunday August 23rd at Charles H Wright Museum of 54800 1WXYZ TV Channel 7 is On Your Side with Healthy Living for Kids 3B Free Immunizations for Children on Sunday August 23rd at Charles H Wright Museum of 54800 2WXYZ TV Channel 7 is On Your Side with Healthy Living for Kids 3B Free Immunizations for Children on Sunday August 23rd at Charles H Wright Museum of 54800 3
...7 - Neurologix, Inc.,(OTCBB:NRGX) today announced ...l The Lancet of positive results from the first ev...the first report of,direct gene transfer into a pa...ative disease., The open label Phase 1 study, cond...ease demonstrated both a lack of adverse,events re...
...th tumor lysate,triggers robust antigen-specific C...an, June 22, 2007,/PRNewswire/ -- MaxCyte, Inc. an...tation at the 13th Annual Meeting of the,Internati...being,held June 24-27, 2007 in Sydney, Australia. ...mature dendritic,cells with tumor lysate triggers ...
Other Medicine Technology:Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 2Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 3Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 4Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 5Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 6MaxCyte and Medinet to Present at the 13th Annual Meeting of the,International Society for Cellular Therapy (ISCT) in Sydney,Australia 2MaxCyte and Medinet to Present at the 13th Annual Meeting of the,International Society for Cellular Therapy (ISCT) in Sydney,Australia 3
...ecific Antigen (PSA) derives its name from its fir...majority of PSA circulates bound to anti-chymotryp...ations of PSA are elevated in patients with prosta...prostatitis [1-3]. In addition, PSA serum levels a...
Ellik Evacuator
Ellik Bladder Evacuator-Disposable
Urology C-Arm Table
Medicine Products: